Related references
Note: Only part of the references are listed.Chemistry and reactivity of ruthenium(II) complexes: DNA/protein binding mode and anticancer activity are related to the complex structure
Ana Rilak Simovic et al.
COORDINATION CHEMISTRY REVIEWS (2019)
Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433
Susan Monro et al.
CHEMICAL REVIEWS (2019)
Unexpected arene ligand exchange results in the oxidation of an organoruthenium anticancer agent: the first X-ray structure of a protein-Ru(carbene) adduct
Matthew P. Sullivan et al.
CHEMICAL COMMUNICATIONS (2018)
Structure-activity relationships for ruthenium and osmium anticancer agents - towards clinical development
Samuel M. Meier-Menches et al.
CHEMICAL SOCIETY REVIEWS (2018)
Thirty Years of the Drug Candidate NAMI-A and the Myths in the Field of Ruthenium Anticancer Compounds: A Personal Perspective
Enzo Alessio
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2017)
Principles and methods used to grow and optimize crystals of protein-metallodrug adducts, to determine metal binding sites and to assign metal ligands
Irene Russo Krauss et al.
METALLOMICS (2017)
Atomic resolution structure of serine protease proteinase K at ambient temperature
Tetsuya Masuda et al.
SCIENTIFIC REPORTS (2017)
CheckMyMetal : a macromolecular metal-binding validation tool
Heping Zheng et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2017)
Protein metalation by metal-based drugs: X-ray crystallography and mass spectrometry studies
L. Messori et al.
CHEMICAL COMMUNICATIONS (2017)
Ru-Based CO releasing molecules with azole ligands: interaction with proteins and the CO release mechanism disclosed by X-ray crystallography
Nicola Pontillo et al.
DALTON TRANSACTIONS (2017)
The metalation of hen egg white lysozyme impacts protein stability as shown by ion mobility mass spectrometry, differential scanning calorimetry, and X-ray crystallography
Matthew P. Sullivan et al.
CHEMICAL COMMUNICATIONS (2017)
{Ru(CO)x}-Core complexes with benzimidazole ligands: synthesis, X-ray structure and evaluation of anticancer activity in vivo
Gabriella Tamasi et al.
DALTON TRANSACTIONS (2017)
The development of RAPTA compounds for the treatment of tumors
Benjamin S. Murray et al.
COORDINATION CHEMISTRY REVIEWS (2016)
Interactions between proteins and Ru compounds of medicinal interest: A structural perspective
Antonello Merlino
COORDINATION CHEMISTRY REVIEWS (2016)
Safety and activity of IT-139, a ruthenium-based compound, in patients with advanced solid tumours: a first-in- human, open-label, dose-escalation phase I study with expansion cohort
Howard A. Burris et al.
ESMO OPEN (2016)
Linking the future of anticancer metal-complexes to the therapy of tumour metastases
Alberta Bergamo et al.
CHEMICAL SOCIETY REVIEWS (2015)
A contribution to the rational design of Ru(CO)(3)Cl2L complexes for in vivo delivery of CO
Joao D. Seixas et al.
DALTON TRANSACTIONS (2015)
Unusual Structural Features in the Lysozyme Derivative of the Tetrakis(acetato)chloridodiruthenium(II,III) Complex
Luigi Messori et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Ruthenium metalation of proteins: the X-ray structure of the complex formed between NAMI-A and hen egg white lysozyme
Luigi Messori et al.
DALTON TRANSACTIONS (2014)
NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application
Robert Trondl et al.
CHEMICAL SCIENCE (2014)
Ligand substitutions between ruthenium-cymene compounds can control protein versus DNA targeting and anticancer activity
Zenita Adhireksan et al.
NATURE COMMUNICATIONS (2014)
Biotransformations of Anticancer Ruthenium(III) Complexes: An X-Ray Absorption Spectroscopic Study
Aviva Levina et al.
CHEMISTRY-A EUROPEAN JOURNAL (2013)
New Uses for Old Drugs: Attempts to Convert Quinolone Antibacterials into Potential Anticancer Agents Containing Ruthenium
Jakob Kljun et al.
INORGANIC CHEMISTRY (2013)
Towards automated crystallographic structure refinement with phenix.refine
Pavel V. Afonine et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2012)
Factors that influence the antiproliferative activity of half sandwich RuII-[9]aneS3 coordination compounds: activation kinetics and interaction with guanine derivatives
Ana Rilak et al.
DALTON TRANSACTIONS (2012)
New half sandwich Ru(II) coordination compounds for anticancer activity
Ioannis Bratsos et al.
DALTON TRANSACTIONS (2012)
Distinct cellular fates for KP1019 and NAMI-A determined by X-ray fluorescence imaging of single cells
Jade B. Aitken et al.
METALLOMICS (2012)
Overview of the CCP4 suite and current developments
Martyn D. Winn et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2011)
A Ruthenium Antimetastasis Agent Forms Specific Histone Protein Adducts in the Nucleosome Core
Bin Wu et al.
CHEMISTRY-A EUROPEAN JOURNAL (2011)
Organometallic Ruthenium(II) Arene Compounds with Antiangiogenic Activity
Patrycja Nowak-Sliwinska et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
CORM-3 Reactivity toward Proteins: The Crystal Structure of a Ru(II) Dicarbonyl-Lysozyme Complex
Teresa Santos-Silva et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)
MolProbity: all-atom structure validation for macromolecular crystallography
Vincent B. Chen et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)
XDS
Wolfgang Kabsch
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
In vivo tumour and metastasis reduction and in vitro effects on invasion assays of the ruthenium RM175 and osmium AFAP51 organometallics in the mammary cancer model
A. Bergamo et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2010)
Pharmacokinetics of a novel anticancer ruthenium complex (KP1019, FFC14A) in a phase I dose-escalation study
Frederike Lentz et al.
ANTI-CANCER DRUGS (2009)
A categorization of metal anticancer compounds based on their mode of action
Teresa Gianferrara et al.
DALTON TRANSACTIONS (2009)
Half-sandwich RuII-[9]aneS3 complexes structurally similar to antitumor-active organometallic piano-stool compounds:: Preparation, structural characterization and in vitro cytotoxic activity
Ioannis Bratsos et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2008)
Triclinic lysozyme at 0.65 Å resolution
Jiawei Wang et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2007)
Phaser crystallographic software
Airlie J. McCoy et al.
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2007)
Half-sandwich RuII-[9] aneS3 complexes with dicarboxylate ligands:: synthesis, characterization and chemical behavior
Ioannis Bratsos et al.
DALTON TRANSACTIONS (2007)
What can be done with a good crystal and an accurate beamline?
Jiawei Wang et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2006)
From bench to bedside -: preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A)
Christian G. Hartinger et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2006)
Anti-tumour activity in non-small cell lung cancer models and toxicity profiles for novel ruthenium(II) based organo-metallic compounds
SM Guichard et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Is the aromatic fragment of piano-stool ruthenium compounds an essential feature for anticancer activity?: The development of new RuII-[9]aneS3 analogues
B Serli et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2005)
In vitro and in vivo evaluation of ruthenium(II)-arene PTA complexes
C Scolaro et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Organometallic chemistry, biology and medicine: ruthenium arene anticancer complexes
YK Yan et al.
CHEMICAL COMMUNICATIONS (2005)
Coot:: model-building tools for molecular graphics
P Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)
Half-sandwich arene ruthenium(II)-enzyme complex
IW McNae et al.
CHEMICAL COMMUNICATIONS (2004)
A phase I and pharmacological study with imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a novel ruthenium anticancer agent
JM Rademaker-Lakhai et al.
CLINICAL CANCER RESEARCH (2004)
In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer
RE Aird et al.
BRITISH JOURNAL OF CANCER (2002)
Electrostatics of nanosystems: Application to microtubules and the ribosome
NA Baker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Catalysis by hen egg-white lysozyme proceeds via a covalent intermediate
DJ Vocadlo et al.
NATURE (2001)
Structure of a serine protease proteinase K from Tritirachium album limber at 0.98 Å resolution
C Betzel et al.
BIOCHEMISTRY (2001)
Share Paper
